Viewing Study NCT03216863



Ignite Creation Date: 2024-05-06 @ 10:17 AM
Last Modification Date: 2024-10-26 @ 12:27 PM
Study NCT ID: NCT03216863
Status: TERMINATED
Last Update Posted: 2018-05-16
First Post: 2017-07-11

Brief Title: Home Respiratory Rehabilitation in Advanced Lung Cancer Chemotherapy Per os
Sponsor: University Hospital Lille
Organization: University Hospital Lille

Study Overview

Official Title: Home Respiratory Rehabilitation in Patients With Lung Cancer Non-small Cell Advanced or Metastatic Treated With Oral Targeted Therapy
Status: TERMINATED
Status Verified Date: 2018-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The feasibility and impact of respiratory rehabilitation RR in patients with advanced or metastatic EGF-R WT or mutated non-small cell lung cancer treated with oral targeted therapy including Inhibitors of EGF-R tyrosine kinases TKI and ALK inhibitors

These patients will benefit at the beginning of the chemotherapy whatever the treatment line of a respiratory rehabilitation The respiratory rehabilitation takes place at the patients home with the HADs cooperation 3 hours per week divided into 2 or 3 sessions There is associated educational nutritional and psychological support for a total duration of 8 weeks
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2015-A00468-41 OTHER ID-RCB number ANSM None